1029 related articles for article (PubMed ID: 9725233)
1. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
2. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
Xu L; Wrona TJ; Dudley JP
Virology; 1996 Jan; 215(2):113-23. PubMed ID: 8560758
[TBL] [Abstract][Full Text] [Related]
3. Mouse mammary tumor virus (MMTV), a retrovirus that exploits the immune system. Genetics of susceptibility to MMTV infection.
Ross SR; Dzuris JL; Golovkina TV; Clemmons WC; van den Hoogen B
Medicina (B Aires); 1997; 57 Suppl 2():34-42. PubMed ID: 9567342
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
Xu L; Wrona TJ; Dudley JP
Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
[TBL] [Abstract][Full Text] [Related]
5. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
[TBL] [Abstract][Full Text] [Related]
6. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
Palmer LD; Saha B; Hodes RJ; Abe R
J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
[TBL] [Abstract][Full Text] [Related]
7. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
[TBL] [Abstract][Full Text] [Related]
8. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
Penninger JM; Wallace VA; Timms E; Mak TW
Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
[TBL] [Abstract][Full Text] [Related]
9. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
10. Retrovirus-host interactions. The mouse mammary tumor virus model.
Acha-Orbea H
Medicina (B Aires); 1997; 57 Suppl 2():43-52. PubMed ID: 9567343
[TBL] [Abstract][Full Text] [Related]
11. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
12. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
13. BALB/Mtv-null mice responding to strong mouse mammary tumor virus superantigens restrict mammary tumorigenesis.
Bhadra S; Lozano MM; Dudley JP
J Virol; 2009 Jan; 83(1):484-8. PubMed ID: 18922863
[TBL] [Abstract][Full Text] [Related]
14. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
15. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H
J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism of resistance to mouse mammary tumor virus infection.
Golovkina TV
J Virol; 2000 Mar; 74(6):2752-9. PubMed ID: 10684291
[TBL] [Abstract][Full Text] [Related]
17. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
18. Massive mammary gland infection and pregnancy-dependent mammary tumor development in mice infected neonatally with mouse mammary tumor virus (SW) but not in mice infected as adults, despite a dramatic local response.
Papiernik M; Waché AC; Pontoux C; Nabarra B
Eur J Immunol; 1997 Sep; 27(9):2145-51. PubMed ID: 9341752
[TBL] [Abstract][Full Text] [Related]
19. [Superantigens and murine mammary tumor retrovirus].
Piazzon I; Nepomnaschy I; Buggiano V; Bekinschtein P; Goldman A; Berguer P; Deroche A; Lombardi G
Medicina (B Aires); 1997; 57 Suppl 2():21-33. PubMed ID: 9567341
[TBL] [Abstract][Full Text] [Related]
20. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
Wrona TJ; Lozano M; Binhazim AA; Dudley JP
J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]